Feedback

Feedback EBIT per Share

The EBIT per Share of Feedback (FDBK.L) as of Nov 4, 2026 is -0.10 GBP. In the previous year, EBIT per Share was -0.27 GBP — a change of -64.41% (higher).

EBIT per Share

-0.10GBP

YoY

-64.41%

Last updated:

EBIT per Share of Feedback is 2025 -0.10 GBP. EBIT per Share of Feedback was 2024 -0.27 GBP. It decreases by -64.41% higher compared to the previous year.

The Feedback EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
-0.29 GBP
Jan 1, 2021
-0.38 GBP
Jan 1, 2022
-0.19 GBP
Jan 1, 2023
-0.26 GBP
Jan 1, 2024
-0.27 GBP
Jan 1, 2025
-0.10 GBP
Jan 1, 2026 (e)
0.00 GBP
Jan 1, 2027 (e)
-0.01 GBP
The Feedback EBIT per Share history
YEAREBIT per ShareYoY
est-0.01GBP—
est0.00GBP-100.00%
-0.10GBP-64.41%
-0.27GBP+5.21%
-0.26GBP+36.12%
-0.19GBP-50.78%
-0.38GBP+34.11%
-0.29GBP-40.29%
-0.48GBP-9.94%
-0.53GBP+117.13%
-0.24GBP-1.35%
-0.25GBP-43.73%
-0.44GBP+36.89%
-0.32GBP-57.16%
-0.75GBP-29.81%
-1.07GBP-19.65%
-1.33GBP+188.71%
-0.46GBP-142.12%
1.10GBP-91.10%
12.32GBP+3,051.34%
0.39GBP-83.85%
2.42GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Feedback Stock analysis

What does Feedback do? Feedback PLC provides imaging tools for clinical decision makers, including TexRAD for medical research and clinical trial management, and Cadran for medical imaging decision support. The company offers Cadran Image Storage Management for image display, review, and enterprise archiving across clinical, non-clinical, and teaching environments. Subsidiaries such as Feedback Black Box Company Limited, Feedback Data GmbH, Brickshield Limited, Cambridge Computed Imaging Limited, TexRAD Limited, and Prostate Checker Ltd support its operations. The firm generates revenue through these products and services targeting medical practitioners, researchers, and pharmaceutical companies involved in cancer detection and treatment workflows. TexRAD is utilized by pharmaceutical companies for managing clinical trials and research, while Cadran and Cadran Image Storage Management are sold to healthcare providers and institutions requiring advanced imaging solutions. The company’s focus on imaging biomarkers for cancer detection attracts partnerships with medical research organizations and hospitals seeking to improve diagnostic accuracy and patient outcomes. Feedback Data GmbH and TexRAD Limited specifically contribute to the development and management of imaging techniques and workflow solutions for the medical sector. The business model centers on selling specialized imaging software and tools to healthcare institutions, pharmaceutical firms, and research organizations. Products like Cadran Image Storage Management are designed for enterprise-level archiving and image handling, appealing to large healthcare systems and academic institutions. TexRAD’s role in clinical trial management ensures recurring revenue streams from pharmaceutical clients who rely on its platform for trial execution and data management. Feedback is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Feedback stock

EBIT per Share of Feedback is -0.10 GBP in 2025.

EBIT per Share of Feedback changed from -0.27 GBP to -0.10 GBP, representing a -64.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Feedback since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Feedback

All Key Metrics — Feedback